The company’s operating income amounted to 4.6 billion euros (about 4.9 billion dollars), an increase of 14.4 percent year-on-year, based on the announced basis.
Net income on a quarterly basis, attributable to shareholders, amounted to 2.82 billion euros, a slight increase over the previous year.
Net sales increased Sanofi In the third quarter, it reached 13.44 billion euros, compared to 11.96 billion dollars a year ago.
Vaccine sales increased by 25.5 percent, driven by sales of influenza and syncytial virus (RSV) vaccinations.
